Skip to main content
TH

Thelium Therapeutics

San Carlos, United States
Last funding
$18.0M
Venture - Series UnknownMay 2022

Thelium Therapeutics is an early-stage preclinical company that develops agents to restore the intestinal barriers in inflammatory diseases.

About Thelium Therapeutics

How much funding has Thelium Therapeutics raised?

Thelium Therapeutics has raised $18.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2022.

Where is Thelium Therapeutics headquartered?

Thelium Therapeutics is headquartered in San Carlos, United States.

What does Thelium Therapeutics do?

Thelium Therapeutics is an early-stage preclinical company that develops agents to restore the intestinal barriers in inflammatory diseases.

What stage is Thelium Therapeutics at?

Thelium Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Thelium Therapeutics — Funding & Investors." VCBacked, May 5, 2022, https://www.vcbacked.co/company/thelium-therapeutics. Accessed November 15, 2026.
APA
VCBacked. (2022). Thelium Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/thelium-therapeutics
Wikipedia (cite web)
{{cite web |title=Thelium Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/thelium-therapeutics |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Thelium Therapeutics? Request a listing update

Founder contacts
m***@theliumtx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →